›Apr 24, 2026phase iv trial initiation109d agoDr Rajendra Prasad Centre for Ophthalmic Sciences — carboxymethylcellulose (Phase IV Trial Initiation)carboxymethylcellulose

Therapy area: Ophthalmology. Indication: Keratoconjunctivitis Sicca (Dry Eye), Unspecified Ophthalmological Disorders

full page →carboxymethylcellulose →source: globaldata

›Apr 25, 2026phase 0 trial completion108d agoExegenesis Bio Inc — EXG-202 (Phase 0 Trial Completion)EXG-202

Therapy area: Ophthalmology. Indication: Age Related Macular Degeneration, Macular Degeneration, Wet (Neovascular / Exudative) Macular Degeneration

full page →EXG-202 →source: globaldata

›Apr 26, 2026phase 2 completion107d agoCentral Council for Research in Unani Medicine — unani medicine (Phase II Trial Completion)unani medicine

Therapy area: Ophthalmology. Indication: Asthenopia (Eye Strain), Keratoconjunctivitis Sicca (Dry Eye), Unspecified Ophthalmological Disorders

full page →unani medicine →source: globaldata

›Apr 26, 2026phase 2 initiation107d agoBeijing Chao-Yang Hospital — oxymetazoline hydrochloride (Phase II Trial Initiation)oxymetazoline hydrochloride

Therapy area: Ophthalmology. Indication: Blepharitis, Ptosis

full page →oxymetazoline hydrochloride →source: globaldata

Week of Apr 27, 2026

›Apr 27, 2026phase 2 completion106d agoSMBT Ayurved College and Hospital — ayurvedic medicine (Phase II Trial Completion)ayurvedic medicine

Therapy area: Ophthalmology. Indication: Keratoconjunctivitis Sicca (Dry Eye)

full page →ayurvedic medicine →source: globaldata

›Apr 27, 2026phase 3 initiation

106d ago

Zhuhai Qiwei Biotechnology Co Ltd — QA-102 (Phase III Trial Initiation)QA-102

Therapy area: Ophthalmology. Indication: Choroidal Neovascularization, Dry (Atrophic) Macular Degeneration, Geographic Atrophy

full page →QA-102 →source: globaldata

›Apr 29, 2026phase 2 completion104d agoMassachusetts Eye and Ear Infirmary — N-acetylcysteine (Phase II Trial Completion)N-acetylcysteine

Therapy area: Ophthalmology. Indication: Cataract, Fuchs Endothelial Corneal Dystrophy (FECD)

full page →N-acetylcysteine →source: globaldata

›Apr 29, 2026phase 3 initiation104d agoAll India Institute of Medical Sciences Bathinda — mitomycin (Phase III Trial Initiation)Jelmyto

Therapy area: Ophthalmology. Indication: Open-Angle Glaucoma

full page →Jelmyto →source: globaldata